Summary
Amgen Inc. filed an 8-K on March 10, 2005, reporting on key updates approved by its Compensation and Management Development Committee on March 7, 2005. The primary focus is on the amendment and restatement of several equity incentive plans, including the 1991 Equity Incentive Plan, the Acquired 1997 Plan (formerly Tularik Inc.), and the 1999 Plan (formerly Immunex Corporation). These amendments primarily adjust terms related to stock options and restricted stock units concerning employee termination due to death, disability, or voluntary retirement, and also address compliance with Section 409A of the Internal Revenue Code. Additionally, the filing details performance award grants for the 2005-2007 period and the 2004-2006 period, as well as approved bonuses for 2004 and established target awards for 2005 under the Executive Incentive Plan (EIP) for named executive officers. The report also notes two amendments to Amgen's bylaws. The first, effective immediately, modifies the requirements and timing for stockholders to submit nominations or other business proposals for annual meetings not included in the company's proxy statement. The second, effective at the May 11, 2005 annual meeting, reduces the authorized number of directors from 13 to 12. These changes indicate proactive adjustments to corporate governance and executive compensation structures.
Key Highlights
- 1Amgen amended and restated its 1991, Acquired 1997, and 1999 Equity Incentive Plans, along with the Performance Award Program.
- 2Key changes to equity award agreements include extended exercise periods and accelerated vesting for stock options and restricted stock units upon death, disability, or voluntary retirement.
- 3Provisions were added to ensure compliance with Section 409A of the Internal Revenue Code for performance units and stock awards.
- 4Performance awards for the 2005-2007 period were granted to named executive officers, building on awards for the 2004-2006 period.
- 5Approved 2004 bonuses totaling over $8 million for named executive officers and established 2005 target awards under the Executive Incentive Plan (EIP) based on Adjusted Net Income.
- 6Bylaw amendments were made to govern stockholder proposals and nominations, and to reduce the authorized number of directors from 13 to 12.
- 7The amendments to the plans and awards are designed to align executive compensation with company performance and to comply with tax regulations.